EUVIMEDEUVIMED entdecken
Crossref

Disulfide-Appended siRNA Nanoeyedrops: Noninvasive Gene Therapy for Targeting Retinal Angiogenesis

Shuya Liu, Dongliang Wang, Sishi Ye, Junjie Zhang, Beiyan Du, Zhijie Lian, Wen Yang, Jie Zhou, Qi Chen, Juan Li iD, Jingying Li iD, Huanghao Yang iD

ACS Nano · 14.10.2025 · 19 (40) · 35333-35347

DOI: 10.1021/acsnano.4c14313 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Nano, online erschienen am 02.10.2025. Verfasst von Shuya Liu und 11 weiteren Autor:innen. Beteiligte Einrichtung: New Cornerstone Science Laboratory, MOE Key Laboratory for Analytical Science of Food Safety and Biology, College of Chemistry, Fuzhou University, Fu…. Hauptthemen laut MEDLINE: RNA, Small Interfering, Genetic Therapy, Disulfides, Retinal Neovascularization. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 53 Literaturangaben. Gefördert von: National Key Research and Development Program of China, Natural Science Foundation of Fujian Province, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RNA, Small InterferingGenetic TherapyDisulfidesRetinal NeovascularizationNanoparticlesAnimalsMiceVascular Endothelial Growth Factor AHumansGene Transfer TechniquesRetinaAngiogenesis

Stichwörter der Autor:innen

Nanoeyedropsocular barrierretinal diseaseself-assemblysmall interfering RNAthiol−disulfide exchange

Substanzen

RNA, Small InterferingDisulfidesVascular Endothelial Growth Factor A

Autor:innen und Institutionen

  • New Cornerstone Science Laboratory, MOE Key Laboratory for Analytical Science of Food Safety and Biology, College of Chemistry, Fuzhou University, Fuzhou 350108, P. R. China.
  • State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, SunYat-sen University, Guangzhou 510060, P. R. China.
  • College of Biological Science and Engineering, Fuzhou University, Fuzhou 350108, P. R. China.
  • Department of Bioengineering and Biopharmaceutics, School of Pharmacy, Fujian Medical University, Fuzhou, Fujian 350122, P. R. China.
  • College of medicine, Fuzhou University, Fuzhou 350108, P. R. China.
  • Zhejiang Cancer Hospital, The Key Laboratory of Zhejiang Province for Aptamers and Theragnostic, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou 310022, P. R. China.

ORCID-Profile: Juan Li, Jingying Li, Huanghao Yang

Förderung

  • National Key Research and Development Program of China
  • Natural Science Foundation of Fujian Province
  • National Natural Science Foundation of China
  • Outstanding Youth Foundation of Fujian Province
  • Zhejiang Leading Innovation and Entrepreneurship Team
  • Pioneer Research and Development Program of Zhejiang

Zitieren

APA

Liu, S., Wang, D., Ye, S., Zhang, J., Du, B., Lian, Z., Yang, W., Zhou, J., Chen, Q., Li, J., Li, J., & Yang, H. (2025). Disulfide-Appended siRNA Nanoeyedrops: Noninvasive Gene Therapy for Targeting Retinal Angiogenesis. ACS Nano, 19(40), 35333-35347. https://doi.org/10.1021/acsnano.4c14313

Vancouver

Liu S, Wang D, Ye S, Zhang J, Du B, Lian Z, et al. Disulfide-Appended siRNA Nanoeyedrops: Noninvasive Gene Therapy for Targeting Retinal Angiogenesis. ACS Nano. 2025;19(40):35333-35347. doi:10.1021/acsnano.4c14313

BibTeX
@article{Liu2025,
  author = {Liu, Shuya and Wang, Dongliang and Ye, Sishi and Zhang, Junjie and Du, Beiyan and Lian, Zhijie and Yang, Wen and Zhou, Jie and Chen, Qi and Li, Juan and Li, Jingying and Yang, Huanghao},
  title = {Disulfide-Appended siRNA Nanoeyedrops: Noninvasive Gene Therapy for Targeting Retinal Angiogenesis},
  journal = {ACS Nano},
  year = {2025},
  volume = {19},
  number = {40},
  pages = {35333--35347},
  doi = {10.1021/acsnano.4c14313}
}
Kostenlos starten →